TL1A inhibitors in inflammatory bowel disease: A systematic review of phase 2 clinical trials.
- DOI
- 10.4103/sjg.sjg_268_26
- Published
- 2026 Sep 1
- Container
- Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.4103/sjg.sjg_268_26,
title = {TL1A inhibitors in inflammatory bowel disease: A systematic review of phase 2 clinical trials.},
author = {Choi JG and Gong EJ and Bang CS and Lee JJ},
year = {2026},
journal = {Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association},
doi = {10.4103/sjg.sjg_268_26},
url = {https://doi.org/10.4103/sjg.sjg_268_26}
}RIS
TY - JOUR TI - TL1A inhibitors in inflammatory bowel disease: A systematic review of phase 2 clinical trials. AU - Choi JG AU - Gong EJ AU - Bang CS AU - Lee JJ PY - 2026 JO - Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association DO - 10.4103/sjg.sjg_268_26 UR - https://doi.org/10.4103/sjg.sjg_268_26 ER -
APA
JG, C., EJ, G., CS, B., & JJ, L. (2026). TL1A inhibitors in inflammatory bowel disease: A systematic review of phase 2 clinical trials.. Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association. https://doi.org/10.4103/sjg.sjg_268_26
Source records
- pubmed · retrieved 2026-09-26T13:14:29.509Z
- europe-pmc · retrieved 2026-09-26T13:14:29.504Z